175 related articles for article (PubMed ID: 718187)
1. Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis.
Spitler LE; Wong P; Sagebiel R
Arch Dermatol; 1978 Oct; 114(10):1501-4. PubMed ID: 718187
[TBL] [Abstract][Full Text] [Related]
2. Oral bacille Calmette Guérin immunostimulation in malignant melanoma.
MacGregor AB; Falk RE; Landi S; Ambus U; Langer B
Surg Gynecol Obstet; 1975 Nov; 141(5):747-54. PubMed ID: 1105837
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
[TBL] [Abstract][Full Text] [Related]
4. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
McCulloch PB; Dent PB; Blajchman M; Muirhead WM; Price RA
Can Med Assoc J; 1977 Jul; 117(1):33-6. PubMed ID: 861909
[TBL] [Abstract][Full Text] [Related]
5. BCG immunotherapy in previously treated malignant melanoma patients.
Mujagić H; Kolarić K; Malenica B; Nola P
Biomedicine; 1979 Jun; 30(2):95-102. PubMed ID: 476270
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
[TBL] [Abstract][Full Text] [Related]
7. [Development in the immunotherapy of malignant melanoma].
Tritsch H
Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
[TBL] [Abstract][Full Text] [Related]
8. Combined immunotherapy in malignant melanoma. Regression of metastatic lesions in two patients concordant in timing with systemic administration of transfer factor and Bacillus Calmette-Guérin.
Spitler LE; Levin AS; Wybran J
Cell Immunol; 1976 Jan; 21(1):1-19. PubMed ID: 764975
[No Abstract] [Full Text] [Related]
9. Immunological factors which influence response to immunotherapy in malignant melanoma.
Morton D; Eilber FR; Malmgren RA; Wood WC
Surgery; 1970 Jul; 68(1):158-63; discussion 163-4. PubMed ID: 10483463
[TBL] [Abstract][Full Text] [Related]
10. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy.
Richman SP; Gutterman JU; Hersh EM
Can Med Assoc J; 1979 Feb; 120(3):322-4, 329. PubMed ID: 371776
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of malignant disease (Part 2).
MacGregor AB; Falk RE
J R Coll Surg Edinb; 1976 Jan; 21(1):43-9. PubMed ID: 765453
[No Abstract] [Full Text] [Related]
14. Immunotherapy in malignant melanomaa.
Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL
Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
[TBL] [Abstract][Full Text] [Related]
15. Multimodality therapy in the treatment of regionally inoperable melanomas and sarcomas.
Yeager RA; Eidemiller LR; Fletcher WS
Surg Gynecol Obstet; 1975 Sep; 141(3):367-70. PubMed ID: 1162562
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of malignant melanoma.
Rosenberg SA
Cancer Treat Rep; 1976 Feb; 60(2):159-63. PubMed ID: 769968
[TBL] [Abstract][Full Text] [Related]
17. Metastasectomy and active specific immunotherapy for a large single melanoma metastasis.
Baars A; van Riel JM; Cuesta MA; Jaspars EH; Pinedo HM; van den Eertwegh AJ
Hepatogastroenterology; 2002; 49(45):691-3. PubMed ID: 12063971
[TBL] [Abstract][Full Text] [Related]
18. [Resection of solitary liver metastases of malignant melanoma].
Stoelben E; Sturm J; Schmoll J; Keilholz U; Saeger HD
Chirurg; 1995 Jan; 66(1):40-3; discussion 43-4. PubMed ID: 7889789
[TBL] [Abstract][Full Text] [Related]
19. Cromolyn prevents bronchospastic attacks caused by Bacillus Calmette Geurin immunotherapy for malignant melanoma patient.
Wishnitzer R; Eliraz A; Fink A
Ann Allergy; 1985 Aug; 55(2):167-9. PubMed ID: 3927789
[TBL] [Abstract][Full Text] [Related]
20. [Intrafocal BCG therapy of metastasizing malignant melanoma].
Kunze J; Lesch R; Plagwitz R; Hagedorn M
Hautarzt; 1978 Nov; 29(11):597-600. PubMed ID: 721465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]